Schizophrenia Research and Care-Advancements and Challenges
The healthcare system's ability to diagnose and care for people with schizophrenia has improved in recent decades, as effective pharmacological and psychosocial interventions are now available. However, schizophrenia remains a leading cause of disability and premature mortality. The utilization...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_132462 | ||
| 005 | 20240108 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20240108s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-9817-8 | ||
| 020 | |a 9783036598161 | ||
| 020 | |a 9783036598178 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-9817-8 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a PSAN |2 bicssc | |
| 100 | 1 | |a Mucci, Armida |4 edt | |
| 700 | 1 | |a Mucci, Armida |4 oth | |
| 245 | 1 | 0 | |a Schizophrenia Research and Care-Advancements and Challenges |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (208 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The healthcare system's ability to diagnose and care for people with schizophrenia has improved in recent decades, as effective pharmacological and psychosocial interventions are now available. However, schizophrenia remains a leading cause of disability and premature mortality. The utilization of pharmacological and psychosocial interventions in the healthcare system, which have the potential to significantly improve the quality of life for people with schizophrenia, heavily depends on medical professionals completing accurate and comprehensive assessments of patients' psychopathologies, cognitive profiles, physical health statuses and any environmental factors that may influence them. This Special Issue reprint on schizophrenia, from the Journal of Clinical Medicine, presents a collection of articles on current approaches to assessment and treatment, as well as new findings and future perspectives of schizophrenia research and care. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Neurosciences |2 bicssc | |
| 653 | |a schizophrenia | ||
| 653 | |a ERP | ||
| 653 | |a mismatch negativity | ||
| 653 | |a MMN | ||
| 653 | |a P3a | ||
| 653 | |a illness duration | ||
| 653 | |a real-life functioning | ||
| 653 | |a motivation circuits | ||
| 653 | |a negative symptoms | ||
| 653 | |a RDoC | ||
| 653 | |a positive valence system | ||
| 653 | |a salience system | ||
| 653 | |a deficit syndrome | ||
| 653 | |a diagnosis | ||
| 653 | |a cognitive function | ||
| 653 | |a social skills training | ||
| 653 | |a physical comorbidities | ||
| 653 | |a childhood abuse | ||
| 653 | |a internalized stigma | ||
| 653 | |a neutrophil-to-lymphocyte ratio | ||
| 653 | |a antipsychotics | ||
| 653 | |a hypothyroidism | ||
| 653 | |a inflammatory markers | ||
| 653 | |a expressive deficits | ||
| 653 | |a experiential deficits | ||
| 653 | |a functioning | ||
| 653 | |a quality of life | ||
| 653 | |a first psychotic episode | ||
| 653 | |a first episode | ||
| 653 | |a emotional processing | ||
| 653 | |a social cognition | ||
| 653 | |a MCCB | ||
| 653 | |a MSCEIT | ||
| 653 | |a real-world studies | ||
| 653 | |a real-world effectiveness | ||
| 653 | |a tolerability | ||
| 653 | |a treatment adherence | ||
| 653 | |a second-generation antipsychotics | ||
| 653 | |a long-acting injectable antipsychotics | ||
| 653 | |a delusional disorders | ||
| 653 | |a psychosis | ||
| 653 | |a sex | ||
| 653 | |a women | ||
| 653 | |a psychopathology | ||
| 653 | |a construct | ||
| 653 | |a schizophrenia spectrum | ||
| 653 | |a renaming | ||
| 653 | |a rethinking | ||
| 653 | |a revising | ||
| 653 | |a effort expenditure | ||
| 653 | |a recent-onset schizophrenia | ||
| 653 | |a persistent negative symptoms | ||
| 653 | |a motivation | ||
| 653 | |a neuropeptide S | ||
| 653 | |a cognitive functioning | ||
| 653 | |a rehabilitation | ||
| 653 | |a AEP | ||
| 653 | |a QEEG | ||
| 653 | |a switch | ||
| 653 | |a extrapyramidal symptoms | ||
| 653 | |a treatment | ||
| 653 | |a cognitive deficits | ||
| 653 | |a self-evaluation of negative symptoms | ||
| 653 | |a health-related quality of life | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/8502 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/132462 |7 0 |z DOAB: description of the publication |